FDA OKs 1st trial to test gene-edited pig livers for treating liver failure

(By: Alexandra Murphy for Becker’s Hospital Review)

The FDA has cleared the first clinical trial to test genetically engineered pig livers in patients who have acute-on-chronic liver failure.

The trial will evaluate the use of a Egenesis porcine liver genetically modified to be more compatible with the human immune system in combination with the OrganOx extracorporeal liver cross-circulation system, according to an April 15 Egenesis news release. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.